natgillin/translations-raw huggingface dataset:
Initiate dosing with 0.75 mg/kg bw subcutaneous every 12 hours (maximum 75 mg for the first two doses only) must be followed by 0.75 mg/kg dosing for the remaining doses.
Odmerjanje začnite z odmerkom 0,75 mg/kg TM subkutano na 12 ur (največ 75 mg samo za prva dva odmerka), nato največ 0,75 mg/kg za preostale odmerke.
Initiate therapy using the bodyweight in kg and the dosing table.
Zdravljenje začnite s pomočjo telesne mase v kg in preglednice odmerjanja.
Initiate treatment with saquinavir 500 mg twice daily with ritonavir 100 mg twice daily for the first 7 days, then saquinavir 1000 mg twice daily with ritonavir 100 mg twice daily in ART- naïve patients.
Pri bolnikih, ki še niso bili zdravljeni z antiretrovirusno terapijo (ART), začnite z zdravljenjem s sakvinavirjem 500 mg dvakrat na dan z ritonavirjem 100 mg dvakrat na dan prvih 7 dni, nato nadaljujte s sakvinavirjem 1000 mg dvakrat na dan z ritonavirjem 100 mg dvakrat na dan.
Initiate treatment with saquinavir 500 mg twice daily with ritonavir 100 mg twice daily for the first 7 days, then saquinavir 1000 mg twice daily with ritonavir 100 mg twice daily in ART- naïve patients.
Pri bolnikih, ki še niso bili zdravljeni z ART, začnite z zdravljenjem s sakvinavirjem 500 mg dvakrat na dan z ritonavirjem 100 mg dvakrat na dan prvih 7 dni, nato nadaljujte s sakvinavirjem 1000 mg dvakrat na dan z ritonavirjem 100 mg dvakrat na dan.
Initiation
Začetek zdravljenja
Initiation of digoxin in patients already taking Kaletra is likely to result in lower than expected increases of digoxin concentrations.
Uvedba digoksina bolnikom, ki že jemljejo zdravilo Kaletra, bo koncentracijo digoksina verjetno zvišala manj, kot bi ga pričakovali.
Initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier is not available or appropriate (see in section 5.1).
Začetek zdravljenja z lamivudinom pride v upoštev le, kadar uporaba drugega protivirusnega zdravila z višjo genetsko pregrado proti odpornosti ni na razpolago oz. ni primerna (glejte poglavje 5.1).
Initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier is not available or appropriate (see section 5.1).
Začetek zdravljenja z lamivudinom pride v upoštev le, kadar uporaba drugega protivirusnega zdravila z višjo genetsko pregrado proti odpornosti ni na razpolago oz. ni primerna (glejte poglavje 5.1).
Initiation of peginterferon alfa-2b is contraindicated in HCV/HIV patients with cirrhosis and a Child- Pugh score ≥ 6.
Začetek zdravljenja s pegiliranim interefonom alfa-2b je kontraindiciran pri HCV/HIV bolnikih s cirozo in z oceno po Child-Pughu > 6.
Initiation of peginterferon alfa-2b is contraindicated in HCV/HIV patients with cirrhosis and a Child-Pugh score ≥6.
Uvedba peginterferona alfa-2b je kontraindicirana pri bolnikih, ki so sočasno okuženi s HCV in HIV ter imajo cirozo jeter z oceno ≥ 6 po Child-Pughu.
Initiation of the study by July 2010
Začetek študije bo v juliju 2010.
Initiation of this medicinal product’s therapy in this population (> 75 years) is not recommended (see sections 4.2, 4.8, and 5.2).
Uvedba tega zdravila v tej populaciji (> 75 let) ni priporočljiva (glejte poglavja 4.2, 4.8 in 5.2).
Initiation of treatment in pregnancy (see section 4.6).
uvajanje zdravljenja med nosečnostjo (glejte poglavje 4.6)
Initiation of treatment in pregnancy (see section 4.6).
Uvajanje zdravljenja med nosečnostjo (glejte poglavje 4.6).
Initiation of treatment in pregnancy (see section 4.6).
Uvedba zdravljenja med nosečnostjo (glejte poglavje 4.6).
Initiation of treatment in pregnancy (see section 4.6).
Začetek zdravljenja med nosečnostjo (glejte poglavje 4.6).
Initiation of treatment in pregnancy (see section 4.6).
Začetek zdravljenja v nosečnosti (glejte poglavje 4.6).
Initiation of treatment is contraindicated during pregnancy (see section 4.3).
Uvedba zdravljenja med nosečnostjo je kontraindicirana (glejte poglavje 4.3).
Initiation of treatment should take into account the combinations of mutations which may negatively impact the virological response to Aptivus, co- administered with low dose ritonavir (see section 5.1).
Pri uvajanju zdravljenja je treba upoštevati kombinacije mutacij, ker lahko negativno vplivajo na virološki odziv na zdravilo Aptivus, ki ga dajemo hkrati z majhnimi odmerki ritonavirja (glejte poglavje 5.1).
Initiation of treatment with Ranexa should be avoided during administration of inducers of CYP3A4 (e.g. rifampicin, phenytoin, phenobarbital, carbamazepine, St. John’s Wort) (see section 4.4).
Uvedbi zdravljenja z zdravilom Ranexa se je treba izogibati med uporabo spodbujevalcev encima CYP3A4 (npr. rifampicina, fenitoina, fenobarbitala, karbamazepina in šentjanževke) (glejte poglavje 4.4).
Initiation of treatment with vemurafenib is not recommended in patients with QTc>500 milliseconds (ms).
Zdravljenja z vemurafenibom ni priporočljivo uvesti pri bolnikih, ki imajo interval
Initiation of Volibris is not recommended for patients with clinically significant anaemia.
Zdravila Volibris ni priporočljivo uvesti bolnikom s klinično pomembno anemijo.
Initiation pack
Začetno pakiranje
Initiation Pack Subcutaneous use
začetno pakiranje subkutana uporaba
Initiation pack.
začetno pakiranje
Initiation pack: 14 tablets
začetno pakiranje: 14 tablet
Initiation pack: 21 tablets (7 x 0.26 mg +
začetno pakiranje: 21 tablet (7 x 0,26 mg + 7 x 0,52 mg
Initiation pack: 28
zgibanka
Initiation pack: 6 pre-filled syringes of 8.8 µg + 6 pre- filled syringes of
Začetno pakiranje: 6 napolnjenih injekcijskih brizg po 8,8 mikrogramov in
Initiation pack: 63 (7 x 3 and 7 x 6) capsules
Pakiranje za začetek zdravljenja: 63 (7 x 3 in 7 x 6) kapsul
INJECT
INJICIRAJTE
Inject 3 ml of FIRMAGON 120 mg slowly, immediately after reconstitution.
Počasi injicirajte 3 ml zdravila FIRMAGON 120 mg takoj po rekonstituciji.
Inject 3 ml of FIRMAGON 120 mg slowly, immediately after reconstitution.*
Počasi injicirajte 3 ml zdravila FIRMAGON 120 mg takoj po rekonstituciji.
Inject 4 ml of FIRMAGON 80 mg slowly, immediately after reconstitution.
Počasi injicirajte 4 ml zdravila FIRMAGON 80 mg takoj po rekonstituciji.
Inject 4 ml of FIRMAGON 80 mg slowly, immediately after reconstitution.*
Počasi injicirajte 4 ml zdravila FIRMAGON 80 mg takoj po rekonstituciji.
Inject air into the product vial. keeping the syringe plunger pressed, turn the system upside down and draw the solution into the syringe by pulling the plunger back slowly.
Medtem ko držite bat brizge pritisnjen, obrnite sistem na glavo in počasi vlecite bat brizge, da se brizga napolni z raztopino.
Inject all of the medication by pushing in the plunger until the plunger head is completely between the needle guard wings (see Figure 5)
Injicirajte vse zdravilo tako, da pritiskate na bat dokler glava bata ni med aktivacijskimi nastavki ščitnika igle (glejte Sliko 5).
Inject all of the medication by pushing in the plunger until the plunger head is completely between the needle guard wings (see Figure 5)
Injicirajte vse zdravilo tako, da pritiskate na bat, dokler glava bata ni med aktivacijskimi nastavki ščitnika igle (glejte Sliko 5).
Inject all of the medicine by pushing in the plunger until the plunger head is completely between the needle guard wings (see figure 7).
Vbrizgajte vso količino zdravila s pritiskom bata noter, da boste glavo bata potisnili vse do predela med krilci ščitnika igle (glejte sliko 7).
Inject all of the solution by slowly and steadily pushing down the plunger.
Počasi in enakomerno potiskajte bat dol, da boste injicirali vso raztopino.
Inject by subcutaneous route one dose (1 ml) of vaccine after reconstitution of the lyophilisate with the solvent, according to the following vaccination schedule:
Po rekonstituciji liofilizirane sestavine z vehiklom injicirajte l odmerek (1 ml) cepiva v podkožje, po naslednjem razporedu:
Inject by subcutaneous route one dose (1 ml) of vaccine after reconstitution of the lyophilisate with the solvent, according to the following vaccination scheme:
Po rekonstituciji liofilizirane sestavine z vehiklom injicirajte 1 ml odmerek cepiva v podkožje, po naslednjem razporedu:
Inject by subcutaneous route one dose (1ml) of vaccine after reconstitution of the lyophilisate with the solvent, according to the following vaccination scheme:
Po rekonstituciji liofilizirane sestavine z vehiklom injicirajte 1 ml odmerek (1 ml) cepiva v podkožje, po naslednjem razporedu:
Inject Humalog as your physician or nurse has taught you.
Zdravilo Humalog si injicirajte, kot vam je naročil vaš zdravnik ali medicinska sestra.
Inject Humalog BASAL under the skin.
Zdravilo Humalog BASAL si injicirajte pod kožo.
Inject Humalog Mix25 under the skin.
Zdravilo Humalog Mix25 si injicirajte pod kožo.
Inject Humalog Mix50 under the skin.
Zdravilo Humalog Mix50 si injicirajte pod kožo.
Inject Humalog under the skin (subcutaneously).
Zdravilo Humalog si injicirajte pod kožo (subkutano).
Inject Humalog under the skin.
Zdravilo Humalog si injicirajte pod kožo.
Inject Imlygic intralesionally into cutaneous, subcutaneous, and/or nodal lesions that are visible, palpable or detectable by ultrasound guidance.
Injicirajte zdravilo Imlygic intralezijsko v kožne, podkožne in/ali nodalne spremembe, ki so vidne, otipljive ali jih je mogoče odkriti ultrazvočno.
Inject immediately using the intramuscular (IM) route, preferably in the deltoid are of the upper arm or in the higher anterolateral area of the thigh.
Injicirajte takoj intramuskularno (i.m.), najbolje v deltoidni predel nadlakti ali visoko v anterolateralni predel stegna.
Inject immediately using the intramuscular (IM) route, preferably in the deltoid area of the upper arm or in the higher anterolateral area of the thigh.
Injicirajte takoj intramuskularno (i.m.), najbolje v deltoidni predel nadlakti ali visoko v anterolateralni predel stegna.
Inject in a different place each time in order to keep your skin healthy.
Vsakič morate injicirati na drugo mesto, da bo vaša koža ostala zdrava.
Inject INCRELEX just under your skin shortly before or after a meal or snack because it may have insulin- like hypoglycaemic effects and so it may decrease blood sugar levels (see hypoglycaemia in section 4).
Zdravilo INCRELEX si injicirajte pod kožo neposredno pred ali po obroku oziroma prigrizku, saj ima zdravilo lahko insulinu podoben hipoglikemični učinek in lahko zniža vrednost krvnega sladkorja (glejte hipoglikemija v poglavju 4).
Inject into a vial of ZYPREXA Powder for Solution for Injection.
Injicirajte v vialo ZYPREXA praška za raztopino za injiciranje.
Inject into Myocet buffer vial to adjust the pH of liposomes.
Injicirajte v vialo s pufrom Myocet in tako uravnajte pH vrednost liposomov.
Inject it into the front of your thighs, upper arms or the front of your waist (abdomen).
Injicirajte ga v sprednji del stegen, nadlakti ali sprednji del trebuha.
Inject largest lesion(s) first.
Najprej injicirajte v največjo spremembo/največje spremembe.
Inject Liprolog as your physician or nurse has taught you.
Zdravilo Liprolog si injicirajte, kot vam je naročil vaš zdravnik ali medicinska sestra.
Inject Liprolog Basal under the skin.
Zdravilo Liprolog Basal si injicirajte pod kožo.
Inject Liprolog Mix25 under the skin.
Zdravilo Liprolog Mix25 si injicirajte pod kožo.
Inject Liprolog Mix50 under the skin.
Zdravilo Liprolog Mix50 si injicirajte pod kožo.
Inject Liprolog under the skin (subcutaneously).
Zdravilo Liprolog si injicirajte pod kožo (subkutano).
Inject Liprolog under the skin.
Zdravilo Liprolog si injicirajte pod kožo.
Inject medicine
Injicirajte si zdravilo
Inject medicine (Figure I)
Injicirajte si zdravilo (slika I)
Inject one dose per boar at least every 6 months.
Injicirajte en odmerek na merjasca najmanj vsakih 6 mesecev.
Inject one dose per fattening pig from the age of 10 weeks.
Z enim odmerkom cepiva cepite prašiče pitance pri starosti 10 tednov.
Inject one dose per gilt before the first mating, or
Injicirajte en odmerek na mladico pred prvim parjenjem, ali
Inject one dose per gilt or sow during each gestation at 3–6 weeks before the expected date of farrowing.
Injicirajte en odmerek na mladico ali svinjo v obdobju 3-6 tednov pred pričakovano gonitvijo
Inject only the dose your doctor has told you following the instructions below.
Po navodilih spodaj si injicirajte samo odmerek, ki vam ga je predpisal zdravnik.
Inject only the dose your doctor has told you.
Injicirajte samo odmerek, ki vam ga je predpisal zdravnik.
Inject Ovitrelle as your doctor or nurse taught you.
Zdravilo Ovitrelle si injicirajte tako, kot vas je naučil vaš zdravnik ali medicinska sestra.
Inject Ovitrelle as your doctor or nurse taught you.
Zdravilo Ovitrelle si injicirajte tako, kot vas je podučil vaš zdravnik ali medicinska sestra.
Inject Ovitrelle as your doctor or nurse taught you.
Zdravilo Ovitrelle si injicirajte, kot vas je naučil vaš zdravnik ali medicinska sestra.
Inject slowly and steadily.
Injicirajte počasi in enakomerno.
Inject slowly over 2 to 5 minutes.
Injicirajte počasi, v času od 2 do 5 minut.
Inject slowly over a period of 5-15 minutes.
Injicirajte počasi v času 5–15 minut.
Inject slowly until the rubber stopper reaches the bottom of the syringe to deliver the volume of 0.05 ml.
Injicirajte počasi, dokler gumijasto tesnilo ne doseže vrha brizge, s čimer odmerite volumen 0,05 ml.
Inject the 1.8 ml of diluent into the vial of Torisel 30 mg concentrate.
Injicirajte teh 1,8 ml vehikla v vialo z zdravilom Torisel 30 mg koncentrat.
Inject the 1.8 ml of extracted diluent into the vial of Torisel 30 mg concentrate.
Injicirajte 1,8 ml vehikla, odvzetega iz priložene viale, v vialo z zdravilom Torisel 30 mg koncentrat.
Inject the air into the vial containing long–acting insulin and pull out the needle.
Injicirajte zrak v vialo z dolgodelujočim insulinom in potegnite iglo iz nje.
Inject the air into the vial: push the needle through the rubber stopper and press the plunger
Injicirajte zrak v vialo: potisnite iglo skozi gumijasti zamašek in pritisnite bat.
inject the amount indicated on the injection button from this OptiSet and then inject the remaining dose using a new OptiSet, or inject the entire dose using a new OptiSet.
S tem OptiSetom injicirate količino, označeno na gumbu celotni odmerek injicirate z novim OptiSetom.
inject the amount indicated on the injection button from this OptiSet and then inject the remaining dose using a new OptiSet, or inject the entire dose using a new OptiSet.
S tem OptiSetom injicirate količino, označeno na gumbu za injiciranje, preostanek odmerka pa injicirate z novim OptiSetom, ali celotni odmerek injicirate z OptiSetom.
inject the amount left in your pen and then use a new pen to give the rest of your dose, or get a new pen and inject the full dose.
injicirate preostalo količino insulina iz peresnika, nato pa za dajanje preostanka svojega odmerka uporabite nov peresnik, ali pa vzamete nov peresnik in si injicirate celoten odmerek.
Inject the content of the syringe into the vial of AVONEX by connecting the pre-filled syringe to the BIO-SET device.
Vsebino injekcijske brizge vbrizgajte v vialo zdravila AVONEX tako, da napolnjeno injekcijsko brizgo povežete z BIO-SET nastavkom.
Inject the diluent by slowly pushing down on the plunger rod (G).
S počasnim potiskanjem bata brizge navzdol vbrizgajte vehikel (G).
Inject the diluent slowly into the sides of the vial containing the lyophilized powder of Xiapex.
Vehikel počasi injicirajte ob steno viale, ki vsebuje liofiliziran prašek zdravila Xiapex.
Inject the dose
Injicirajte odmerek
Inject the dose
Napolnitev odmerka
Inject the dose as you were trained to by your doctor or nurse
Injicirajte odmerek, kot vas je poučil vaš zdravnik ali medicinska sestra.
Inject the dose by pressing the push–button all the way in until 0 lines up with the pointer.
Odmerek injicirajte tako, da potisni gumb pritisnete do konca in se oznaka 0 uravna s kazalnikom.
Inject the dose promptly after removing the needle cover.
Odmerek si injicirajte takoj po snetju pokrovčka igle.
Inject the dose promptly after removing the needle cover.
Po odstranitvi pokrovčka z igle takoj injicirajte zdravilo.
Inject the dose promptly after removing the needle cover.
Po odstranitvi pokrovčka z igle, takoj injicirajte zdravilo.
Inject the dose.
Injicirajte odmerek.
Inject the dose:
Injiciranje odmerka:
Inject the entire content of the solvent syringe into the vial containing the powder.
Izbrizgajte celotno vsebino brizge z vehiklom v vialo s praškom.
Inject the entire contents of the pre-filled pen.
Injicirajte celotno vsebino napolnjenega injekcijskega peresnika.
Inject the entire contents of the pre-filled syringe.
Injicirajte celotno vsebino napolnjene injekcijske brizge.
Inject the entire contents of the syringe into the corresponding Docefrez vial.
Vbrizgajte celotno vsebino injekcijske brizge v ustrezno vialo Docefreza.
Inject the entire contents of the syringe into the corresponding Docetaxel Teva Pharma vial.
4.1.3 Vbrizgajte celotno vsebino injekcijske brizge v ustrezno vialo zdravila Docetaxel Teva Pharma.
Inject the entire contents of the syringe into the vial containing the Savene powder.
Vbrizgajte celotno vsebino brizge v vialo s praškom Savene.
Inject the entire contents of the syringe into the vial of powder, holding the syringe against the vial wall.
elotno vsebino injekcijske brizge injicirajte v vialo s praškom, pri tem pa držite iglo injekcijske brizge ob steno viale.
Inject the liquid as soon as you have mixed it.
Tekočino injicirajte takoj, ko jo zmešate.
Inject the liquid slowly and evenly, always keeping your skin pinched.
Tekočino injicirajte počasi in enakomerno; kožo medtem držite med prstoma.
Inject the medicine by using a slow, steady push (push the plunger all the way in until the syringe is empty).
S počasnim in enakomernim pritiskom vbrizgajte zdravilo (potiskajte bat do konca, dokler injekcijska brizga ni prazna).
Inject the medicine slowly by pushing steadily on the plunger until all the medicine is injected and the syringe is empty.
Zdravilo injicirajte počasi z enakomernim pritiskanjem na bat, dokler ne injicirate celotne količine zdravila in izpraznite injekcijsko brizgo.
Inject the medicine.
Injicirajte zdravilo.
Inject the NeoRecormon solution.
Injicirajte raztopino zdravila NeoRecormon.
Inject the Plegridy pen exactly as your doctor or nurse has shown you.
Zdravilo Plegridy napolnjen injekcijski peresnik si injicirajte natančno tako, kot vam je pokazal zdravnik ali medicinska sestra.
Inject the Plegridy pre-filled syringe exactly as your doctor or nurse has shown you.
Zdravilo Plegridy napolnjena injekcijska brizga si injicirajte natančno tako, kot vam je pokazal zdravnik ali medicinska sestra.
Inject the prescribed dose subcutaneously as directed by your doctor, nurse or pharmacist.
Predpisani odmerek injicirajte pod kožo po navodilu, ki ste ga dobili od vašega zdravnika, medicinske sestre ali farmacevta.
Inject the reconstituted solution as instructed by your doctor or nurse.
Pripravljeno raztopino injicirajte, kot sta vam naročila zdravnik ali medicinska sestra.
Inject the reconstituted solution as instructed by your doctor or nurse.
Pripravljeno raztopino injicirajte, kot vam je naročil vaš zdravnik ali medicinska sestra.
Inject the required dose (in mg) via a single injection (one shot) into a 250 ml non-PVC infusion bag containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion or with 5% glucose solution in a glass bottle.
Potrebni odmerek (v mg) naenkrat (z enim pritiskom) vbrizgajte v 250-ml infuzijsko vrečko, katere material ne vsebuje PVC, in ki vsebuje bodisi 5% raztopino glukoze bodisi raztopino natrijevega klorida 9 mg/ml (0,9 %) za infundiranje ali v ali steklenico, v kateri je 5 % raztopina glukoze za infundiranje.
Inject the required premix volume into a 250 ml infusion bag or bottle containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
Potrebno količino osnovne raztopine vbrizgajte v 250-ml infuzijsko vrečko ali steklenico, v kateri je 5 % raztopina glukoze ali 9 mg/ml (0,9 %) raztopina natrijevega klorida za infundiranje.
Inject the required premix volume into a 250 ml infusion bag or bottle containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
Potrebno količino osnovne raztopine vbrizgajte v 250-ml infuzijsko vrečko ali steklenico, v kateri je 5 % raztopina glukoze ali raztopina 9 mg/ml (0,9%) natrijevega klorida za infundiranje
Inject the required premix volume into a 250 ml non-PVC infusion bag containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
4.2.2 Potrebno količino osnovne raztopine vbrizgajte v 250 ml infuzijsko vrečko (ne iz PVC-ja), v kateri je 5 % raztopina glukoze ali 9 mg/ml (0,9 %) raztopina natrijevega klorida za infundiranje.
Inject the required premix volume into a 250 ml non-PVC infusion bag containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
b.2.2 Potrebno količino osnovne raztopine vbrizgajte v 250 ml infuzijsko vrečko (ne iz PVC-ja), v kateri je 5 % raztopina glukoze ali 9 mg/ml (0,9 %) raztopina natrijevega klorida za infundiranje.
Inject the required premix volume into a 250 ml non-PVC infusion bag containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
Potrebno količino osnovne raztopine vbrizgajte v 250 ml infuzijsko vrečko (ne iz PVC-ja), v kateri je 5 % raztopina glukoze ali 9 mg/ml (0,9 %) raztopina natrijevega klorida za infundiranje.
Inject the required volume back into the opened Savene diluent bottle (see point 3.1.5).
Vbrizgajte potreben volumen nazaj v odprto steklenico z vehiklom Savene (glejte točko 3.1.5).
Inject the required volume of reconstituted solution into a 250 ml infusion bag or bottle containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
Potrebno količino osnovne raztopine vbrizgajte v 250-ml infuzijsko vrečko ali steklenico, v kateri je 5 % raztopina glukoze ali raztopina natrijevega klorida 9 mg/ml (0.9%) za infundiranje.
Inject the solution as a 3-5 second bolus intravenous injection through a peripheral or central intravenous catheter into a vein.
Raztopino injicirajte v obliki 3-5 sekund trajajoče bolusne intravenske injekcije skozi periferno ali centralno intravensko cevko v veno.
Inject the solution by gently pushing the plunger all the way down.
S počasnim pritiskom bata navzdol injicirajte raztopino.
Inject the solution by pushing gently on the plunger.
Raztopino injicirajte tako, da nežno pritiskate na bat.
Inject the solution subcutaneously, under a 45-90°angle.
Raztopino injicirajte subkutano, pod kotom 45-90 °.
Inject the solution subcutaneously, under a 45-90°angle.
Raztopino injicirajte subkutano, pod kotom 45-90°.
Inject the solvent into the vial containing the powder by slowly pushing the syringe plunger down (F).
Vehikel vbrizgajte v vialo s praškom s počasnim potiskanjem bata brizge navzdol (F).
Inject the suspension through the plastic cannula, no smaller than 20 G at a maximum injection rate of 1.0 ml/s.
Injicirajte suspenzijo skozi plastično kanilo, ki ni manjša od 20 G, pri maksimalni hitrosti injiciranja 1,0 ml/s.
Inject the withdrawn volume rapidly into 250 ml of sodium chloride 9 mg/ml (0.9%) solution for injection to ensure adequate mixing.
Hitro injicirajte odvzeti volumen v 250 ml raztopine natrijevega klorida 9 mg/ml (0,9 %) za injiciranje, da zagotovite ustrezno mešanje.
Inject this medicine once each week on the same day.
To zdravilo si injicirajte enkrat na teden, vedno na isti dan.
Inject too much insulin.
i injicirate preveč insulina,
Inject too much insulin.
če si injicirate preveč insulina,
Inject too much insulin.
če ste injicirali prevelik odmerek insulina,
Inject under the skin, as you were taught.
Raztopino vbrizgajte pod kožo, kot so vas naučili.
Inject your dose
Injiciranje
Inject your dose using another syringe.
Svoj odmerek si injicirajte z drugo injekcijsko brizgo.
Inject your insulin as your healthcare professional has shown you.
Vbrizgajte si insulin, kot vam je pokazal vaš zdravnik.